Post a Free Blog

Submit A Press Release

Thursday, March 28, 2024
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Action
Animation
ATP Tour (ATP)
Auto Racing
Baseball
Basketball
Boxing
Breaking News
Business
Business
Business Newsletter
Call of Duty (CALLOFDUTY)
Canadian Football League (CFL)
Car
Celebrity
Champions Tour (CHAMP)
Comedy
CONCACAF
Counter Strike Global Offensive (CSGO)
Crime
Defense of the Ancients (DOTA)
Documentary and Foreign
Drama
eSports
European Tour (EPGA)
Fashion
FIFA
FIFA Women’s World Cup (WWC)
FIFA World Cup (FIFA)
Fighting
Football
Formula 1 (F1)
Fortnite
Golf
Health
Hockey
Horror
IndyCar Series (INDY)
International Friendly (FRIENDLY)
Kids & Family
League of Legends (LOL)
LPGA
Madden
Major League Baseball (MLB)
Mixed Martial Arts (MMA)
MLS
Movie and Music
Movie Trailers
Mystery
NASCAR Cup Series (NAS)
National Basketball Association (NBA)
National Football League (NFL)
National Hockey League (NHL)
National Women's Soccer (NWSL)
NBA Development League (NBAGL)
NBA2K
NCAA Baseball (NCAABBL)
NCAA Basketball (NCAAB)
NCAA Football (NCAAF)
NCAA Hockey (NCAAH)
Olympic Mens (OLYHKYM)
Other
Other Sports
Overwatch
PGA
Politics
Premier League (PREM)
Romance
Sci-Fi
Science
Soccer
Sports
Sports
Technology
Tennis
Truck Series (TRUCK)
Ultimate Fighting Championship (UFC)
Uncategorized
US
Valorant
Women’s National Basketball Association (WNBA)
Women’s NCAA Basketball (WNCAAB)
World
World Cup Qualifier (WORLDCUP)
WTA Tour (WTA)
Xfinity (XFT)
XFL
-- Advertisement --spot_img
HomeBusinessGates foundation pledges $120 million for generic antiviral COVID pill for low...

Gates foundation pledges $120 million for generic antiviral COVID pill for low income nations

 

On Wednesday, the Bill and Melinda Gates Foundations said that they would donate up to $120 million, to provide access of Merck’s antiviral COVID pill molnupiravir to poor nations who have been struggling to gain access to vaccine supplies or to distribute them.

The foundation released a statement which said that money from the Gates foundation would be used to support activities that were necessary to develop and manufacture a generic version of the oral pill–molnupiravir that has been developed by Merck.

The statement also mentioned that the funding would be made after molnupiravir gained approval from the Food and Drug Administration (FDA). The regulatory body is expected to schedule a meeting with outside experts on November 30. If the FDA clears the drug, it could become the first pill that will be used orally to treat COVID-19.

The foundation also said that this funding would build on its ongoing efforts put in to deal with the pandemic from its beginning. It said that it had funded $1.9 billion for improving access to COVID-19 vaccines, for treatments and for tests.

Merck and its partner Ridgeback Biotherapeutics said that early results on molnupiravir showed that high risk patients who took the pill within five days after they were infected with COVID-19 had halved their hospitalization and death rates.

Other big pharma have also started trials with oral pills to prevent or treat COVID-19 infections. Pfizer and Roche are among those who have started trials. Merck has been the first to state that they have obtained good results.

It is now up to the FDA and its independent experts to study the results and if satisfied, to give this new antiviral pill molnupiravir approval so that it can be produced as early as possible and generic versions could be distributed among low income countries.

Source Forbes ABC News

Subscribe to get Latest News Updates

Latest News Articles

You may like more
more

Robinhood Gains 3 percent on Credit Card Launch Plans

Robinhood Markets (NASDAQ:HOOD) stock rose more than 3% intra-day...

Bloom Energy’s Price Target Cut at Susquehanna

Susquehanna analysts adjusted their price target for Bloom Energy...

Nio Shares Drops 6 percent Following Slashed Q1 Delivery Outlook

NIO (NYSE:NIO) shares fell more than 6% intra-day today...

nCino Shares Jump 19 percent Following Q4 Earnings

nCino (NASDAQ:NCNO) shares surged more than 19% intra-day today...